What are the sex and gender differences in the incidence, prevalence, clinical presentation, and management of vitreous hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sex and Gender Differences in Vitreous Hemorrhage

Men experience posterior vitreous detachment (PVD)—the primary cause of spontaneous vitreous hemorrhage—at an earlier age than women, and male sex is independently associated with higher risk of both vitreous hemorrhage incidence and subsequent retinal detachment complications.

Incidence and Prevalence Differences

The evidence demonstrates clear sex-based disparities in vitreous hemorrhage epidemiology:

  • Male predominance is consistent across studies: Population-based data from Taiwan shows male sex as a significant independent risk factor for vitreous hemorrhage (HR=1.07, p=0.03) 1. In pediatric populations, males comprised 82% of vitreous hemorrhage cases 2.

  • Earlier onset in men: PVD, which causes most spontaneous vitreous hemorrhages, typically occurs between ages 45-65 but develops earlier in men than women 3. This temporal difference means men face vitreous hemorrhage risk at younger ages.

  • Higher retinal detachment risk in men: Following vitreous hemorrhage from PVD, men have nearly 3-fold higher risk of developing rhegmatogenous retinal detachment (HR=2.90,95% CI 1.64-5.12, p<0.001) compared to women 4. This represents a critical morbidity difference affecting visual outcomes.

Clinical Presentation Differences

The presentation patterns show important sex-related variations:

In traumatic vitreous hemorrhage (which accounts for 68.5% of pediatric cases), males experience both blunt trauma (64.7% of male cases) and penetrating trauma more frequently than females (57.7% of female cases) 2. This reflects gender-based differences in injury patterns and occupational/recreational exposures.

Symptom presentation appears similar between sexes—both experience photopsias (light flashes) and floaters (myodesopsias) as cardinal symptoms of PVD-related hemorrhage. However, the timing and severity differ: men's earlier PVD onset means they present with these symptoms at younger ages 3.

Treatment and Outcomes

Surgical management patterns show sex-related outcome differences:

  • Male sex was significantly associated with severe visual loss in pediatric vitreous hemorrhage cases (p<0.001) 2, suggesting either more severe initial presentations or worse treatment responses in males.

  • The higher retinal detachment rate in men (17% overall, but HR=2.90 in males) means men more frequently require urgent surgical intervention 4. Retinal detachment risk plateaus at 20 days, creating a critical early monitoring window where sex-based risk stratification matters.

  • Spontaneous clearance rates (62% overall) do not appear to differ by sex in the available evidence, though men's higher complication rates may reduce the feasibility of conservative observation 4.

Clinical Algorithm Based on Sex

For male patients with vitreous hemorrhage from PVD:

  • Implement more intensive early monitoring (first 20 days when RD risk peaks)
  • Lower threshold for early vitrectomy given 3-fold higher RD risk
  • Consider prophylactic intervention more readily, especially in younger males

For female patients with vitreous hemorrhage from PVD:

  • Standard monitoring protocols appropriate
  • Conservative observation more likely to succeed
  • Later age of onset means concurrent age-related factors (cataract, medical comorbidities) require consideration

Important Caveats

The interaction between age and sex is critical: older patients (>65-73 years) show significantly lower RD risk (HR=0.25-0.27) regardless of sex 4. This means the male disadvantage is most pronounced in younger age groups.

Anticoagulation use (HR=2.20 for VH incidence) and dialysis status affect both sexes but may compound male risk given their baseline higher incidence 1, 5.

The evidence does not address potential hormonal, anatomical, or behavioral mechanisms underlying these sex differences, representing a knowledge gap requiring further investigation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.